Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Average cost to bring a pharmaceutical asset to market among mid cap biopharma companies in 2010, 2016, 2017, and 2018
(in billion U.S. dollars)
Cost to bring biopharmaceutical assets in mid cap companies to market 2010-2018
This statistic shows the cost to bring biopharmaceutical asset to market among mid-cap biopharma companies in 2010, 2016, 2017, and 2018. According to the data, in 2017, the cost to bring an asset to market was around 2.17 billion U.S. dollars.
Average cost to bring a pharmaceutical asset to market among mid cap biopharma companies in 2010, 2016, 2017, and 2018
(in billion U.S. dollars)
Cost in billion U.S. dollars
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

December 2018

Region

Worldwide

Survey time period

2010, 2016, 2017, and 2018

Cost to bring biopharmaceutical assets in mid cap companies to market 2010-2018
This statistic shows the cost to bring biopharmaceutical asset to market among mid-cap biopharma companies in 2010, 2016, 2017, and 2018. According to the data, in 2017, the cost to bring an asset to market was around 2.17 billion U.S. dollars.
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Statistics on "Biotech industry"
  • Global overview
  • U.S. companies
  • Research & development
The most important statistics
  • Products
  • Funding/investment
  • Biotech in agriculture
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.